Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.

about

Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib

P2860

Q58729853-9BE1C25D-115B-49A7-9C26-CA880D38D16C

P2860

Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q47169310

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pan-phosphatidylinositol 3-kin ...... fractory non-Hodgkin lymphoma.

@en

Pan-phosphatidylinositol 3-kin ...... fractory non-Hodgkin lymphoma.

@nl

type

Item

label

Pan-phosphatidylinositol 3-kin ...... fractory non-Hodgkin lymphoma.

@en

Pan-phosphatidylinositol 3-kin ...... fractory non-Hodgkin lymphoma.

@nl

prefLabel

Pan-phosphatidylinositol 3-kin ...... fractory non-Hodgkin lymphoma.

@en

Pan-phosphatidylinositol 3-kin ...... fractory non-Hodgkin lymphoma.

@nl

P1476

Pan-phosphatidylinositol 3-kin ...... fractory non-Hodgkin lymphoma.

@en

P2093

Anas Younes

http://www.w3.org/2001/XMLSchema#string

Chaitali Babanrao Pisal

http://www.w3.org/2001/XMLSchema#string

Dolores Caballero Barrigon

http://www.w3.org/2001/XMLSchema#string

Eva González Barca

http://www.w3.org/2001/XMLSchema#string

Gilles Salles

http://www.w3.org/2001/XMLSchema#string

John Gerecitano

http://www.w3.org/2001/XMLSchema#string

Mehmet Turgut

http://www.w3.org/2001/XMLSchema#string

Oliver Kong

http://www.w3.org/2001/XMLSchema#string

Ranjana Tavorath

http://www.w3.org/2001/XMLSchema#string

Robert Gregory Bociek

http://www.w3.org/2001/XMLSchema#string

P2860

P110delta, a novel phosphoinositide 3-kinase in leukocytes

p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes

Global cancer statistics, 2012

A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

Cancer statistics, 2016

PI3K and cancer: lessons, challenges and opportunities

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.

Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.

P304

2104-2112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2017.169656

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Martinelli

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28971900

http://www.w3.org/2001/XMLSchema#string

P932

5709110

http://www.w3.org/2001/XMLSchema#string

Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.

about

P2860

P2860

Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932